Contrasting effects of hypochlorous acid and hydrogen peroxide on endothelial permeability: prevention with cAMP drugs.
Activated polymorphonuclear leukocytes generate a cascade of reduced oxygen metabolites. In addition to their antimicrobial role, hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) function as inflammatory mediators and increase the protein permeability of the vascular endothelium. The objectives of the present study were to compare the effects of H2O2 and HOCl with respect to relative potencies and the time course and magnitude of changes in cell shape and permeability of endothelial cell monolayers derived from bovine pulmonary artery, to determine if HOCl produced by conversion of H2O2 with myeloperoxidase and Cl- produces comparable results as the direct administration of HOCl, and to show that adenosine 3',5'-cyclic monophosphate (cAMP)-enhancing agents can prevent the increased endothelial permeability induced by HOCl and H2O2. HOCl given directly or produced by myeloperoxidase, H2O2, and Cl- caused faster and greater changes in cell shape (cell retraction), electrical resistance, and protein permeability (125I-labeled albumin clearance) of endothelial cell monolayers than induced by H2O2. HOCl (10 to 100 microM) induced these changes within 1 to 3 min, whereas H2O2 (50 to 400 microM) required approximately 30 min. 8-Bromo-cAMP prevented the increased endothelial protein permeability induced by HOCl or H2O2, but isoproterenol only prevented the H2O2 response. Thus, HOCl at a much lower concentration caused a faster and greater increase in endothelial permeability in vitro than H2O2, and an increased intracellular level of cAMP prevented the increased permeability induced by either oxidant.
Ochoa
L
L
Department of Physiology and Cell Biology, Albany Medical College, New York 12208, USA.
Waypa
G
G
Mahoney
J R
JR
Rodriguez
L
L
Minnear
F L
FL
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000418:Albumins / Q000493:pharmacokinetics; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects* / Q000502:physiology; D002417:Cattle; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D017097:Electric Impedance; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000009:adverse effects / Q000494:pharmacology*; D006997:Hypochlorous Acid / Q000009:adverse effects / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D008857:Microscopy, Interference; D018375:Neutrophil Activation / Q000187:drug effects; D011651:Pulmonary Artery / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D015203:Reproducibility of Results
D000318:Adrenergic beta-Agonists; D000418:Albumins; D015124:8-Bromo Cyclic Adenosine Monophosphate; D006997:Hypochlorous Acid; D006861:Hydrogen Peroxide; D007545:Isoproterenol